RE: Takeover bid - in light of the CEO’s 437p SP target17 Jun 2025 15:09
Not sure where you would find £470m of synergies. On the cost side Metro's total cost base is c.£500m most of which ultimately relates to the current account business which has no synergy with Shawbrook cost base. You could maybe get to £100m across central functions etc. Plus there is some balance sheet optimisation from replacing Metro's excess liquidity with Shawbrook assets, and possibly a lower marginal cost for funding additional growth in Shawbrook- possibly worth another £100m. Against that, you have to fair value the branch related assets, which might drop CET1 by c£150-£200m which will need to be pumped straight in (i.e. if you bought it for £1b it would cost you £1.2b in cash) . That said, I agree that £200-£250m of standalone profit is not that tough a target for Metro to get to if rates hold up- but I would value that at £1.6bn (8x earnings so £2.30 a share) not £4.37 which in my understanding is more of a technical price at which the CEO's upside tops out. Not a target really (i.e. certainly not where current guidance gets you). Galinski could try and hold out for "full value" but he will have to find an exit at some point and Pollen have been the only persistently interested party. So I reckon a bit of a discount to full value, but more than the £1.20-£1.30p where we are trading now would be the likely take out price if it happens, which is 50-50 at best